APO Research
Talk to an analyst

APO RESEARCH · REPORT

Soluble Guanylate Cyclase

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Soluble Guanylate Cyclase Market Outlook and Growth Opportunities 2026

19 December 2025198 pages

Choose your research edition.

Industry ResearchSoluble Guanylate Cyclase Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Soluble Guanylate Cyclase Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Soluble Guanylate Cyclase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Soluble Guanylate Cyclase Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Soluble Guanylate Cyclase Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Soluble Guanylate Cyclase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Soluble Guanylate Cyclase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Soluble Guanylate Cyclase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Soluble Guanylate Cyclase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Soluble Guanylate Cyclase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Soluble Guanylate Cyclase market include Bayer AG, Topadur Pharma AG, SynZyme Technologies LLC, NicOx SA, Ironwood Pharmaceuticals Inc and Boehringer Ingelheim GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Soluble Guanylate Cyclase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Soluble Guanylate Cyclase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Soluble Guanylate Cyclase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Soluble Guanylate Cyclase market size, projected growth trends, production technologies, key applications, and end-use industries.

Soluble Guanylate Cyclase Segment by Company

Bayer AG

Topadur Pharma AG

SynZyme Technologies LLC

NicOx SA

Ironwood Pharmaceuticals Inc

Boehringer Ingelheim GmbH

Soluble Guanylate Cyclase Segment by Type

Hydroxyurea

IW-1701

BI-703704

BAY-1636183

Others

Soluble Guanylate Cyclase Segment by Application

Ophthalmology

Cardiovascular

Gastrointestinal

Metabolic Disorders

Others

Soluble Guanylate Cyclase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Soluble Guanylate Cyclase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Soluble Guanylate Cyclase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Soluble Guanylate Cyclase significant trends, drivers, influence factors in global and regions.

6. To analyze Soluble Guanylate Cyclase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soluble Guanylate Cyclase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Soluble Guanylate Cyclase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soluble Guanylate Cyclase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Soluble Guanylate Cyclase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Soluble Guanylate Cyclase industry.

Chapter 3: Detailed analysis of Soluble Guanylate Cyclase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Soluble Guanylate Cyclase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Soluble Guanylate Cyclase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Soluble Guanylate Cyclase Industry Trends Table 2. Soluble Guanylate Cyclase Industry Drivers Table 3. Soluble Guanylate Cyclase Industry Opportunities and Challenges Table 4. Soluble Guanylate Cyclase Industry Restraints Table 5. Global Soluble Guanylate Cyclase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Soluble Guanylate Cyclase Revenue Share by Company (2021-2026) Table 7. Global Soluble Guanylate Cyclase Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Soluble Guanylate Cyclase Sales Volume Share by Company (2021-2026) Table 9. Global Soluble Guanylate Cyclase Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Soluble Guanylate Cyclase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Soluble Guanylate Cyclase Key Company Manufacturing Base & Headquarters Table 12. Global Soluble Guanylate Cyclase Company, Product Type & Application Table 13. Global Soluble Guanylate Cyclase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Soluble Guanylate Cyclase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Hydroxyurea Table 18. Significant Companies of IW-1701 Table 19. Significant Companies of BI-703704 Table 20. Significant Companies of BAY-1636183 Table 21. Significant Companies of Others Table 22. Global Soluble Guanylate Cyclase Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 23. Global Soluble Guanylate Cyclase Sales Volume by Type (2021-2026) & (W Units) Table 24. Global Soluble Guanylate Cyclase Sales Volume by Type (2027-2032) & (W Units) Table 25. Global Soluble Guanylate Cyclase Sales Volume Share by Type (2021-2026) Table 26. Global Soluble Guanylate Cyclase Sales Volume Share by Type (2027-2032) Table 27. Global Soluble Guanylate Cyclase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Soluble Guanylate Cyclase Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Soluble Guanylate Cyclase Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Soluble Guanylate Cyclase Sales Value Share by Type (2021-2026) Table 31. Global Soluble Guanylate Cyclase Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Ophthalmology Table 33. Significant Companies of Cardiovascular Table 34. Significant Companies of Gastrointestinal Table 35. Significant Companies of Metabolic Disorders Table 36. Significant Companies of Others Table 37. Global Soluble Guanylate Cyclase Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Soluble Guanylate Cyclase Sales Volume by Application (2021-2026) & (W Units) Table 39. Global Soluble Guanylate Cyclase Sales Volume by Application (2027-2032) & (W Units) Table 40. Global Soluble Guanylate Cyclase Sales Volume Share by Application (2021-2026) Table 41. Global Soluble Guanylate Cyclase Sales Volume Share by Application (2027-2032) Table 42. Global Soluble Guanylate Cyclase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Soluble Guanylate Cyclase Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Soluble Guanylate Cyclase Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Soluble Guanylate Cyclase Sales Value Share by Application (2021-2026) Table 46. Global Soluble Guanylate Cyclase Sales Value Share by Application (2027-2032) Table 47. Global Soluble Guanylate Cyclase Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 48. Global Soluble Guanylate Cyclase Sales by Region (2021-2026) & (W Units) Table 49. Global Soluble Guanylate Cyclase Sales Market Share by Region (2021-2026) Table 50. Global Soluble Guanylate Cyclase Sales by Region (2027-2032) & (W Units) Table 51. Global Soluble Guanylate Cyclase Sales Market Share by Region (2027-2032) Table 52. Global Soluble Guanylate Cyclase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Soluble Guanylate Cyclase Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Soluble Guanylate Cyclase Sales Value Share by Region (2021-2026) Table 55. Global Soluble Guanylate Cyclase Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Soluble Guanylate Cyclase Sales Value Share by Region (2027-2032) Table 57. Global Soluble Guanylate Cyclase Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Soluble Guanylate Cyclase Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Soluble Guanylate Cyclase Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 60. Global Soluble Guanylate Cyclase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Soluble Guanylate Cyclase Sales by Country (2021-2026) & (W Units) Table 62. Global Soluble Guanylate Cyclase Sales Market Share by Country (2021-2026) Table 63. Global Soluble Guanylate Cyclase Sales by Country (2027-2032) & (W Units) Table 64. Global Soluble Guanylate Cyclase Sales Market Share by Country (2027-2032) Table 65. Global Soluble Guanylate Cyclase Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Soluble Guanylate Cyclase Sales Value Market Share by Country (2021-2026) Table 67. Global Soluble Guanylate Cyclase Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Soluble Guanylate Cyclase Sales Value Market Share by Country (2027-2032) Table 69. Bayer AG Company Information Table 70. Bayer AG Business Overview Table 71. Bayer AG Soluble Guanylate Cyclase Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Bayer AG Soluble Guanylate Cyclase Product Portfolio Table 73. Bayer AG Recent Development Table 74. Topadur Pharma AG Company Information Table 75. Topadur Pharma AG Business Overview Table 76. Topadur Pharma AG Soluble Guanylate Cyclase Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Topadur Pharma AG Soluble Guanylate Cyclase Product Portfolio Table 78. Topadur Pharma AG Recent Development Table 79. SynZyme Technologies LLC Company Information Table 80. SynZyme Technologies LLC Business Overview Table 81. SynZyme Technologies LLC Soluble Guanylate Cyclase Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. SynZyme Technologies LLC Soluble Guanylate Cyclase Product Portfolio Table 83. SynZyme Technologies LLC Recent Development Table 84. NicOx SA Company Information Table 85. NicOx SA Business Overview Table 86. NicOx SA Soluble Guanylate Cyclase Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. NicOx SA Soluble Guanylate Cyclase Product Portfolio Table 88. NicOx SA Recent Development Table 89. Ironwood Pharmaceuticals Inc Company Information Table 90. Ironwood Pharmaceuticals Inc Business Overview Table 91. Ironwood Pharmaceuticals Inc Soluble Guanylate Cyclase Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Ironwood Pharmaceuticals Inc Soluble Guanylate Cyclase Product Portfolio Table 93. Ironwood Pharmaceuticals Inc Recent Development Table 94. Boehringer Ingelheim GmbH Company Information Table 95. Boehringer Ingelheim GmbH Business Overview Table 96. Boehringer Ingelheim GmbH Soluble Guanylate Cyclase Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Boehringer Ingelheim GmbH Soluble Guanylate Cyclase Product Portfolio Table 98. Boehringer Ingelheim GmbH Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Soluble Guanylate Cyclase Distributors List Table 102. Soluble Guanylate Cyclase Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Soluble Guanylate Cyclase Product Image Figure 2. Global Soluble Guanylate Cyclase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Soluble Guanylate Cyclase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Soluble Guanylate Cyclase Sales (2021-2032) & (W Units) Figure 5. Global Soluble Guanylate Cyclase Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Soluble Guanylate Cyclase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Hydroxyurea Image Figure 10. IW-1701 Image Figure 11. BI-703704 Image Figure 12. BAY-1636183 Image Figure 13. Others Image Figure 14. Global Soluble Guanylate Cyclase Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Soluble Guanylate Cyclase Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Soluble Guanylate Cyclase Sales Volume Share by Type (2021-2032) Figure 17. Global Soluble Guanylate Cyclase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Soluble Guanylate Cyclase Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Soluble Guanylate Cyclase Sales Value Share by Type (2021-2032) Figure 20. Ophthalmology Image Figure 21. Cardiovascular Image Figure 22. Gastrointestinal Image Figure 23. Metabolic Disorders Image Figure 24. Others Image Figure 25. Global Soluble Guanylate Cyclase Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Soluble Guanylate Cyclase Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Soluble Guanylate Cyclase Sales Volume Share by Application (2021-2032) Figure 28. Global Soluble Guanylate Cyclase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Soluble Guanylate Cyclase Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Soluble Guanylate Cyclase Sales Value Share by Application (2021-2032) Figure 31. Global Soluble Guanylate Cyclase Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 32. Global Soluble Guanylate Cyclase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Soluble Guanylate Cyclase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Soluble Guanylate Cyclase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Soluble Guanylate Cyclase Sales Value (2021-2032) & (US$ Million) Figure 36. North America Soluble Guanylate Cyclase Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Soluble Guanylate Cyclase Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Soluble Guanylate Cyclase Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Soluble Guanylate Cyclase Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Soluble Guanylate Cyclase Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Soluble Guanylate Cyclase Sales Value (2021-2032) & (US$ Million) Figure 42. South America Soluble Guanylate Cyclase Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Soluble Guanylate Cyclase Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Soluble Guanylate Cyclase Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Soluble Guanylate Cyclase Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Soluble Guanylate Cyclase Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Hydroxyurea
  • IW-1701
  • BI-703704
  • BAY-1636183
  • Others
Applications
  • Ophthalmology
  • Cardiovascular
  • Gastrointestinal
  • Metabolic Disorders
  • Others
Companies covered
  • Bayer AG
  • Topadur Pharma AG
  • SynZyme Technologies LLC
  • NicOx SA
  • Ironwood Pharmaceuticals Inc
  • Boehringer Ingelheim GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Soluble Guanylate Cyclase Sales Value (2021-2032)
  4. 1.2.2 Global Soluble Guanylate Cyclase Sales Volume (2021-2032)
  5. 1.2.3 Global Soluble Guanylate Cyclase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Soluble Guanylate Cyclase Market Dynamics
  1. 2.1 Soluble Guanylate Cyclase Industry Trends
  2. 2.2 Soluble Guanylate Cyclase Industry Drivers
  3. 2.3 Soluble Guanylate Cyclase Industry Opportunities and Challenges
  4. 2.4 Soluble Guanylate Cyclase Industry Restraints
3 Soluble Guanylate Cyclase Market by Company
  1. 3.1 Global Soluble Guanylate Cyclase Company Revenue Ranking in 2025
  2. 3.2 Global Soluble Guanylate Cyclase Revenue by Company (2021-2026)
  3. 3.3 Global Soluble Guanylate Cyclase Sales Volume by Company (2021-2026)
  4. 3.4 Global Soluble Guanylate Cyclase Average Price by Company (2021-2026)
  5. 3.5 Global Soluble Guanylate Cyclase Company Ranking (2024-2026)
  6. 3.6 Global Soluble Guanylate Cyclase Company Manufacturing Base and Headquarters
  7. 3.7 Global Soluble Guanylate Cyclase Company Product Type and Application
  8. 3.8 Global Soluble Guanylate Cyclase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Soluble Guanylate Cyclase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Soluble Guanylate Cyclase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Soluble Guanylate Cyclase Market by Type
  1. 4.1 Soluble Guanylate Cyclase Type Introduction
  2. 4.1.1 Hydroxyurea
  3. 4.1.2 IW-1701
  4. 4.1.3 BI-703704
  5. 4.1.4 BAY-1636183
  6. 4.1.5 Others
  7. 4.2 Global Soluble Guanylate Cyclase Sales Volume by Type
  8. 4.2.1 Global Soluble Guanylate Cyclase Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Soluble Guanylate Cyclase Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Soluble Guanylate Cyclase Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Soluble Guanylate Cyclase Sales Value by Type
  12. 4.3.1 Global Soluble Guanylate Cyclase Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Soluble Guanylate Cyclase Sales Value by Type (2021-2032)
  14. 4.3.3 Global Soluble Guanylate Cyclase Sales Value Share by Type (2021-2032)
5 Soluble Guanylate Cyclase Market by Application
  1. 5.1 Soluble Guanylate Cyclase Application Introduction
  2. 5.1.1 Ophthalmology
  3. 5.1.2 Cardiovascular
  4. 5.1.3 Gastrointestinal
  5. 5.1.4 Metabolic Disorders
  6. 5.1.5 Others
  7. 5.2 Global Soluble Guanylate Cyclase Sales Volume by Application
  8. 5.2.1 Global Soluble Guanylate Cyclase Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Soluble Guanylate Cyclase Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Soluble Guanylate Cyclase Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Soluble Guanylate Cyclase Sales Value by Application
  12. 5.3.1 Global Soluble Guanylate Cyclase Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Soluble Guanylate Cyclase Sales Value by Application (2021-2032)
  14. 5.3.3 Global Soluble Guanylate Cyclase Sales Value Share by Application (2021-2032)
6 Soluble Guanylate Cyclase Regional Sales and Value Analysis
  1. 6.1 Global Soluble Guanylate Cyclase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Soluble Guanylate Cyclase Sales by Region (2021-2032)
  3. 6.2.1 Global Soluble Guanylate Cyclase Sales by Region: 2021-2026
  4. 6.2.2 Global Soluble Guanylate Cyclase Sales by Region (2027-2032)
  5. 6.3 Global Soluble Guanylate Cyclase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Soluble Guanylate Cyclase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Soluble Guanylate Cyclase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Soluble Guanylate Cyclase Sales Value by Region (2027-2032)
  9. 6.5 Global Soluble Guanylate Cyclase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Soluble Guanylate Cyclase Sales Value (2021-2032)
  12. 6.6.2 North America Soluble Guanylate Cyclase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Soluble Guanylate Cyclase Sales Value (2021-2032)
  15. 6.7.2 Europe Soluble Guanylate Cyclase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Soluble Guanylate Cyclase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Soluble Guanylate Cyclase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Soluble Guanylate Cyclase Sales Value (2021-2032)
  21. 6.9.2 South America Soluble Guanylate Cyclase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Soluble Guanylate Cyclase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Soluble Guanylate Cyclase Sales Value Share by Country, 2025 VS 2032
7 Soluble Guanylate Cyclase Country-level Sales and Value Analysis
  1. 7.1 Global Soluble Guanylate Cyclase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Soluble Guanylate Cyclase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Soluble Guanylate Cyclase Sales by Country (2021-2032)
  4. 7.3.1 Global Soluble Guanylate Cyclase Sales by Country (2021-2026)
  5. 7.3.2 Global Soluble Guanylate Cyclase Sales by Country (2027-2032)
  6. 7.4 Global Soluble Guanylate Cyclase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Soluble Guanylate Cyclase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Soluble Guanylate Cyclase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Soluble Guanylate Cyclase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Soluble Guanylate Cyclase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Soluble Guanylate Cyclase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer AG
  2. 8.1.1 Bayer AG Company Information
  3. 8.1.2 Bayer AG Business Overview
  4. 8.1.3 Bayer AG Soluble Guanylate Cyclase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bayer AG Soluble Guanylate Cyclase Product Portfolio
  6. 8.1.5 Bayer AG Recent Developments
  7. 8.2 Topadur Pharma AG
  8. 8.2.1 Topadur Pharma AG Company Information
  9. 8.2.2 Topadur Pharma AG Business Overview
  10. 8.2.3 Topadur Pharma AG Soluble Guanylate Cyclase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Topadur Pharma AG Soluble Guanylate Cyclase Product Portfolio
  12. 8.2.5 Topadur Pharma AG Recent Developments
  13. 8.3 SynZyme Technologies LLC
  14. 8.3.1 SynZyme Technologies LLC Company Information
  15. 8.3.2 SynZyme Technologies LLC Business Overview
  16. 8.3.3 SynZyme Technologies LLC Soluble Guanylate Cyclase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 SynZyme Technologies LLC Soluble Guanylate Cyclase Product Portfolio
  18. 8.3.5 SynZyme Technologies LLC Recent Developments
  19. 8.4 NicOx SA
  20. 8.4.1 NicOx SA Company Information
  21. 8.4.2 NicOx SA Business Overview
  22. 8.4.3 NicOx SA Soluble Guanylate Cyclase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 NicOx SA Soluble Guanylate Cyclase Product Portfolio
  24. 8.4.5 NicOx SA Recent Developments
  25. 8.5 Ironwood Pharmaceuticals Inc
  26. 8.5.1 Ironwood Pharmaceuticals Inc Company Information
  27. 8.5.2 Ironwood Pharmaceuticals Inc Business Overview
  28. 8.5.3 Ironwood Pharmaceuticals Inc Soluble Guanylate Cyclase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ironwood Pharmaceuticals Inc Soluble Guanylate Cyclase Product Portfolio
  30. 8.5.5 Ironwood Pharmaceuticals Inc Recent Developments
  31. 8.6 Boehringer Ingelheim GmbH
  32. 8.6.1 Boehringer Ingelheim GmbH Company Information
  33. 8.6.2 Boehringer Ingelheim GmbH Business Overview
  34. 8.6.3 Boehringer Ingelheim GmbH Soluble Guanylate Cyclase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Boehringer Ingelheim GmbH Soluble Guanylate Cyclase Product Portfolio
  36. 8.6.5 Boehringer Ingelheim GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Soluble Guanylate Cyclase Value Chain Analysis
  2. 9.1.1 Soluble Guanylate Cyclase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Soluble Guanylate Cyclase Sales Mode & Process
  6. 9.2 Soluble Guanylate Cyclase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Soluble Guanylate Cyclase Distributors
  9. 9.2.3 Soluble Guanylate Cyclase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst